The effect of green coffee supplement on glycemic control, inflammatory index, lipid profile and anthropometry in type 2 diabetic patients

Shiraz University of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新: 2020年8月17日

试验速览

暂无简介。

•Definitive diagnosis of type 2 diabetes in patients was made by an associate clinical physician under ADA criteria.
•Duration of type 2 diabetes is at least 3 years
•The type and dose of drugs used in the last 6 months is constant
•No chronic (chronic, renal, hepatic, pulmonary, or chronic or acute inflammatory diseases, especially acute inflammation of the pancreas and endocarditis)No heart disease, short bowel syndrome, allergies and thyroid disease
•Do not use any dietary supplements in the last 6 months
•No pregnancy and lactation
•Willingness to participate in the study
•No allergies to green coffee

•Pregnancy during the study period
•Changes in medication dosage during the study period
•Occurrence of one of the above diseases during the study period
•Dissatisfaction with continuing to participate in the study
•Do not take less than 80% of the allocated amount of green coffee tablets or do not follow the study design for more than a week

发起方